Beclometasone/formoterol/glycopyrronium pMDI for maintenance treatment of moderate to severe COPD

Description

In this Product Explainer, Dr Philip Lee explains the role of beclomethasone/ formoterol/ glycopyrronium pressurised metered dose inhalers (pMDIs) for maintenance treatment of adults with moderate to severe COPD who are not adequately treated by ICS/LABA or LABA/LAMA (7 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Christopher Soo

Dr Christopher Soo

ADHD in Children – Practical Advice and Update for GPs

Prof Rod Baber

Prof Rod Baber

Oral vs Transdermal MHT – Which Option for Who?

Prof Jason Ong

Prof Jason Ong

The Mpox Emergency – What You Need to Know

Dr Janet Green

Dr Janet Green

Infant and Specialty Formula – What’s in Them and Why

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Dr Philip Lee

expert

Dr Philip Lee

Respiratory and Sleep Physician; Consultant, Respiratory and Sleep Medicine, St George and Northern Beaches Hospitals

Date published: 14 August 2024